Alger Mid Cap Focus Fund Class Y (ALOYX)

Overview

The fund is designed to cater to investors seeking to capitalize on opportunities within the mid-cap segment of the market, with a specialized focus on the health care and software industries. By allocating at least 80% of its net assets, plus any borrowings for investment purposes, into equity securities of mid-cap companies, the fund aims to leverage the growth potential of these entities. Additionally, with a strategic emphasis on investing at least 25% of its total assets in specific industries that are crucial to the health care and technology sectors, the fund seeks to benefit from sector-specific growth. This focused approach may lead to a concentration of investments in any one of these industries, underlining the fund's specialized investment strategy. The fund's structure as non-diversified allows it to pursue a targeted investment approach, potentially leading to higher risks, but also offering the possibility for significant returns.

Products and Services

The fund offers an investment product with a distinctive focus on mid-cap companies and specialized industries:

• Equity Securities of Mid-Cap Companies: The backbone of the fund's investment strategy, focusing on equity securities of mid-cap companies permits the fund to pursue growth by tapping into the potential of companies within this segment of the market. The choice of mid-cap companies is driven by the view that these entities offer a balance between the rapid growth potential of smaller firms and the stability of larger corporations.
• Specialized Industry Investments: With a mandate to allocate at least 25% of its total assets to industries critical to health care and technology, the fund offers exposure to sectors with high growth potential. The targeted industries include:
  • Health Care Equipment & Supplies: Investments in companies that manufacture and supply medical equipment and supplies, catering to the growing demand for health care services.
  • Health Care Technology: Focusing on companies that develop technology solutions for the health care industry, including medical billing, patient care management systems, and more.
  • Biotechnology: Investments in companies engaged in the research, development, and distribution of biotechnological products and services, offering potential for significant advances in medical science.
  • Life Sciences Tools & Services: Catering to companies that provide essential tools, services, and technology for the research and development activities within the life sciences industry.
  • Software: Targeting the software industry, with a focus on companies developing software solutions for various applications, including but not limited to health care-related technologies.